AuriGen Medical

AuriGen Medical

Verified
Medical device start up, developing the next generation in left atrial appendage implant technology for the treatment of medication resistant longstanding persistent atrial fibrillation. Learn more

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
EUR201820192020
EV / revenue00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x

Source: Dealroom estimates

  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor investor

$0.0

round
investor

$0.0

round
investor

$0.0

round
investor

$0.0

round
investor

$0.0

round
investor

$0.0

round

€1.0m

Early VC
Total Funding000k

Recent News about AuriGen Medical

Edit
More about AuriGen Medical
Edit

Manufacturer of minimally invasive devices intended to treat patients suffering from complex chronic cardiac disease. The company's devices are built around custom left atrial appendage (LAA) occluder implants, to which synergistic modules like cardiac monitoring, ablation, or both modules can be added, offering cost-benefit treatment without the need for anti-coagulants and anti-arrhythmic medicines resulting in significant improvements in patient outcomes.

Keywords: Healthcare Devices, Services, Supplies, Arrhythmia Therapy, Atrial Fibrillation Treatment, Heart Care, Heart Failure, Implants Technology, Medical Devices, Medical Technology Company, Remote Monitoring, Remote Monitoring Technology, Stroke Therapeutics, Telemedicine.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.